Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease.

Jing-Houng Wang Hsin-You Ou Yi-Hao YenChao-Hung HungSheng-Nan Lu

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

For NAFLD patients, CAP exhibited good performance in monitoring clinically relevant decline of hepatic steatosis in MRI-PDFF. With the cutoffs of -46 dB/m or -15%, ΔCAP is useful in excluding clinical relevant outcome achievement.

Keyphrases

end stage renal disease
ejection fraction
magnetic resonance imaging
prognostic factors
chronic kidney disease
peritoneal dialysis
computed tomography
magnetic resonance
patient reported outcomes